参考文献
|
-
Anagnostis, P.,Athyros, V.G.,Adamidou, F.,Panagiotou, A.,Kita, M.,Karagiannis, A.,Mikhailidis, D.P.(2011).Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.Diabetes Obes. Metab.,13,302-312.
-
Baggio, L.L.,Drucker, D.J.(2007).Biology of incretins: GLP-1 and GIP.Gastroenterology,132,2131-2157.
-
Chang, G.,Zhang, D.,Yu, H.,Zhang, P.,Wang, Y.,Zheng, A.,Qin, S.(2013).Cardioprotective effects of exenatide against oxidative stress-induced injury.Int. J. Mol. Med.,32,1011-1020.
-
Drucker, D.J.,Nauck, M.A.(2006).The incretin system: glucagonlike peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.Lancet,368,1696-1705.
-
Harkavyi, A.,Whitton, P.S.(2010).Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection.Brit. J. Pharmacol.,159,495-501.
-
Issan, Y.,Kornowski, R.,Aravot, D.,Shainberg, A.,Laniado-Schwartzman, M.,Sodhi, K.,Abraham, N.G.,Hochhauser, E.(2014).Heme oxygenase-1 induction improves cardiac function following myocardial ischemia by reducing oxidative stress.PLoS One,9,e92246.
-
Kayama, Y.,Raaz, U.,Jagger, A.,Adam, M.,Schellinger, I.N.,Sakamoto, M.,Suzuki, H.,Toyama, K.,Spin, J.M.,Tsao, P.S.(2015).Diabetic cardiovascular disease induced by oxidative stress.Int. J. Mol. Sci.,16,25234-25263.
-
Li, B.,Kim, D.S.,Yadav, R.K.,Kim, H.R.,Chae, H.J.(2015).Sulforaphane prevents doxorubicin-induced oxidative stress and cell death in rat H9c2 cells.Int. J. Mol. Med.,36,53-64.
-
Li, H.H.,Willis, M.S.,Lockyer, P.,Miller, N.,McDonough, H.,Glass, D.J.,Patterson, C.,Glass, D.J.,Patterson, C.(2007).Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitindependent coactivation of Forkhead proteins.J. Clin. Invest.,117,3211-3223.
-
Lovshin, J.A.,Drucker D.J.(2009).Incretin-based therapies for type 2 diabetes mellitus.Nat. Rev. Endocrinol.,5,262-269.
-
Mangmool, S.,Hemplueksa, P.,Parichatikanond, W.,Chatipakorn, N.(2015).Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes.Mol. Endocrinol.,29,583-596.
-
Mannucci, E.,Rotella, C.M.(2008).Future perspectives on glucagonlike peptide-1, diabetes and cardiovascular risk.Nutr. Metab. Cardiovasc. Dis.,18,639-645.
-
Nepal, S.,Kim, M.J.,Subedi, A.,Lee, E.S.,Yong, C.S.,Kim, J.A.,Kang, W.,Kwak, M.K.,Arya, D.S.,Park, P.H.(2012).Globular adiponectin inhibits ethanol-induced apoptosis in HepG2 cells through heme oxygenase-1 induction.Biochem. Pharmacol.,84,974-983.
-
Oeseburg, H.,de Boer, R.A.,Buikema, H.,van der Harst, P.,van Gilst, W.H.,Silljé, H.H.(2010).Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.Arterioscler. Thromb. Vasc. Biol.,30,1407-1414.
-
Robinson, E.,Cassidy, R.S.,Tate, M.,Zhao, Y.,Lockhart, S.,Calderwood, D.,Church, R.,McGahon, M.K.,Brazil, D.P.,Mc-Dermott, B.J.,Green, B.D.,Grieve, D.J.(2015).Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix.Basic Res. Cardiol.,110,20.
-
Roul, D.,Recchia, F.A.(2015).Metabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome.Antioxid. Redox Signal.,22,1502-1514.
-
Rubler, S.,Dlugash, J.,Yuceoglu, Y.Z.,Kumral, T.,Branwood, A.W.,Grishman, A.(1972).New type of cardiomyopathy associated with diabetic glomerulosclerosis.Am. J. Cardiol.,30,595-602.
-
Song, B.,Zhang, H.,Jiang, L.,Chi, Y.,Tian, J.,Du, W.Y.B.,Han, Z.(2015).Down-regulation of lipocalin 2 suppresses the growth of human lung adenocarcinoma through oxidative stress involving Nrf2/HO-1 signaling.Acta Biochim. Biophys. Sin.,47,805-814.
-
Su, J.D.,Yen, J.H.,Li, S.,Weng, C.Y.,Lin, M.H.,Ho, C.T.,Wu, M.J.(2012).3',4'-didemethylnobiletin induces phase II detoxification gene expression and modulates PI3K/Akt signaling in PC12 cells.Free Radic. Biol. Med.,52,126-141.
-
Tsai, C.Y.,Wang, C.C.,Lai, T.Y.,Tsu, H.N.,Wang, C.H.,Liang, H.Y.,Kuo, W.W.(2013).Antioxidant effects of diallyl trisulfide on high glucose-induced apoptosis are mediated by the PI3K/Aktdependent activation of Nrf2 in cardiomyocytes.Int. J. Cardiol.,168,1286-1297.
-
Tsai, H.Y.,Huang, P.H.,Lin, F.Y.,Chen, J.S.,Lin, S.J.,Chen, J.W.(2013).Ginkgo biloba extract reduces high-glucose-induced endothelial reactive oxygen species generation and cell adhesion molecule expression by enhancing HO-1 expression via Akt/eNOS and p38 MAP kinase pathways.Eur. J. Pharm. Sci.,48,803-811.
-
Tsutsumi, Y.M.,Tsutsumi, R.,Hamaguchi, E.,Sakai, Y.,Kasai, A.,Ishikawa, Y.,Yokoyama, U.,Tanaka, K.(2014).Exendin-4 ameliorates cardiac ischemia/reperfusion injury via caveolae and caveolins-3.Cardiovasc. Diabetol.,13,132.
-
Wang, C.,Chen, X.,Ding, X.,He, Y.,Gu, C.,Zhou, L.(2015).Exendin-4 promotes beta cell proliferation via PI3k/Akt signalling pathway.Cell. Physiol. Biochem.,35,2223-2232.
-
Yang, H.,Li, H.,Wang, Z.,Shi, Y.,Jiang, G.,Zeng, F.(2013).Exendin-4 ameliorates renal ischemia-reperfusion injury in the rat.J. Surg. Res.,185,825-832.
-
Yi, B.,Hu, X.,Wen, Z.,Zhang, T.,Cai, Y.(2014).Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits hyperglycemiainduced apoptosis in myocytes by suppressing receptor for advanced glycation end products expression.Exp. Ther. Med.,8,1185-1190.
-
Younce, C.W.,Niu, J.,Ayala, J.,Burmeister, M.A.,Smith, L.H.,Kolattukudy, P.,Ayala, J.E.(2014).Exendin-4 improves cardiac function in mice overexpressing monocyte chemoattractant protein-1 in cardiomyocytes.J. Mol. Cell. Cardiol.,76,172-176.
-
Zhang, G.,Wang, Q.,Zhou, Q.,Wang, R.,Xu, M.,Wang, H.,Wang, L.,Wilcox, C.S.,Liu, R.,Lai, E.Y.(2016).Protective effect of tempol on acute kidney injury through PI3K/Akt/Nrf2 signaling pathway.Kidney Blood Press Res.,41,129-138.
-
Zhao, R.,Feng, J.,He, G.(2016).Hypoxia increases Nrf2-induced HO-1 expression via the PI3K/Akt pathway.Front. Biosci. (Landmark Ed.),21,385-396.
-
Zhao, S.M.,Wang, Y.L.,Guo, C.Y.,Chen, J.L.,Wu, Y.Q.(2014).Progressive decay of Ca2+ homeostasis in the development of diabetic cardiomyopathy.Cardiovasc. Diabetol.,13,75.
|